Updated:17 May 2013 03:40:00 PM(IST)
Sensex20286.12
38.79 0.19%
Nifty6187.30
17.40 0.28%
Midcap6613.98
21.77 0.33%
Smallcap6199.19
8.25 0.13%
Glaxosmithkline Pharma Ltd :
ISIN: INE159A01016 | NSE: GLAXO | Industry: Pharmaceuticals - Multinational | BSE Code: 500660 | Comments
| Price Information | |
| • Open | 2286.00 |
| • High | 2331.00 |
| • Low | 2240.00 |
| • Previous Close | 2278.70 |
| • Shares Traded | 4949 |
| • 52 Wk High Price | 2522.00 |
| • 52 Wk High Date | 07-05-2013 |
| • 52 Wk Low Price | 1916.00 |
| • 52 Wk Low Date | 04-07-2012 |
| • Face Value | 10.00 |
| Fundamentals | |
| • Market Capital (Rs.cr) | 19300.60 |
| • EPS (Rs.)(TTM) | 77.61 |
| • P/E Ratio(TTM) | 29.37 |
| • Book Value (Rs.) | 237.30 |
| • Price to Book Value | 9.60 |
| • Equity (Rs.cr.) | 84.70 |
| • Traded Value (Rs.lac) | 49.10 |
| Corporate Actions | |
| Ex-Date | Purpose (Rs.) |
| 2011-03-14 | 400% Dividend (40) |
| 2012-03-29 | 450% Dividend (45) |
| 2013-04-04 | 500% Dividend (50) |
| Index Names | |
| • BSE-200 | |
| • BSE-500 | |
| • BSE HC | |
| • CNX Nifty Jr. | |
| Related Companies | ||
| Stock Name | Price | |
| PHARMACIAHEALTH | 132.85 | - |
| ASTRAZEN | 799.50 | |
| BOEHRINGERMERGE | 132.00 | - |
| ABBOTINDIA | 1450.65 | |
| BURROUGHSWEL | 897.20 | - |
| WYETH | 820.20 | |
| MERCK | 658.15 | |
| SMITHB | 123.15 | - |
| FULFORD | 636.00 | - |
| NOVARTIND | 560.40 | |
| Share Tips for Glaxosmithkline Pharma Ltd |
| SENSEX TIPS : Sensex falls 61 points in (10:20AM, Aug 30 '12) |
| POSITIONAL : GLAXO ABOVE 2050 OPENS F (10:50AM, Jul 10 '12) |
| share market tips : SENSEX TRADES UP 85 (11:46AM, May 22 '12) |
| SENSEX FLAT WITH POSITIVE BIAS AT OPEN (01:21PM, May 15 '12) |
| SENSEX TRADES UP 67 POINTS; METAL, BAN (12:10PM, May 14 '12) |
| Mutual funds holding in Glaxosmithkline Pharma Ltd |
| SBI Magnum Multiplier Plus 93 - Growth |
| Kotak Opportunities Fund - Growth |
| Birla Sun Life Mid Cap Fund - Plan A - Growth |
| DSP BlackRock Top 100 Equity Fund - Growth |
| Birla Sun Life Equity Fund - Growth |
| Key Financials | Latest Qrtr. | Trailing Yr. | Full Yr. |
| • Year End | Mar, 2013 | Mar, 2013 | Dec, 2012 |
| • Sales (Rs.cr) | 632.14 | 2639.66 | 2630.30 |
| • Net Profit (Rs.cr) | 170.11 | 657.35 | 673.94 |
| • Net Profit Var (%) | -9.00 | 38.00 | 14.00 |
| • EPS (Rs) | - | 77.61 | 72.10 |
| • P/E Ratio | - | 29.37 | 31.60 |
| • Operating Profit Margin | - | 29.75 | - |
| • CPS (Rs.) | - | - | 74.20 |
| • P/C Ratio | - | - | 30.70 |
| • Div% | - | - | 500.00 |
| Announcements | |
| 08-11-2011 | GlaxoSmithKline Pharmaceuticals appoints additional director |
| 13-08-2011 | GlaxoSmithKline Pharmaceuticals appoints directors |
| 14-02-2011 | GlaxoSmithKline Pharmaceuticals recommends dividend |
| 28-04-2012 | GlaxoSmithKline Pharmaceuticals to announce financial results |
| 23-07-2011 | GlaxoSmithKline Pharmaceuticals to announce Q2 results |
| 20-10-2011 | GlaxoSmithKline Pharmaceuticals to announce Q3 results |
| 04-02-2013 | GlaxoSmithKline Pharmaceuticals to consider dividend |
| 10-04-2013 | GlaxoSmithKline Pharmaceuticals to hold AGM |
Gross Deliverables
Date
Del. Shares
Trd. Qty.
Del.(%)
Del. Value
Turnover
17-05-2013
2307
4949
46.62
5354893
11283.40
13-05-2013
1431
2279
62.79
3333586
5331.54
11-05-2013
93
137
67.88
215058
317.00
10-05-2013
2359
4152
56.82
5494111
9670.64
03-05-2013
1162
2209
52.60
2644422
4989.83
Note:
- % change is w.r.t. Prev. Close
- On ex-date % change is w.r.t. open price
- On the date ofmovement of security from/to trade for trade segment, %
change is w.r.t. open price
- 52 week high & 52 week low prices are based on the trade date &
not adjusted with corporate action
Comment(s) posted on Glaxosmithkline Pharma Ltd
©2011 Appuonline.com